Kilitch Financial Statements From 2010 to 2025

Stocks . India . 
Stock . Kilitch Drugs Limited
KILITCH Stock   353.15  7.90  2.29%   
Kilitch Drugs financial statements provide useful quarterly and yearly information to potential Kilitch Drugs Limited investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Kilitch Drugs financial statements helps investors assess Kilitch Drugs' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Kilitch Drugs' valuation are summarized below:
Gross Profit
808.4 M
Profit Margin
0.1073
Market Capitalization
5.8 B
Enterprise Value Revenue
3.011
Revenue
1.8 B
We have found eighty-seven available fundamental ratios for Kilitch Drugs, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of Kilitch Drugs last-minute fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year.

Kilitch Drugs Total Revenue

889.65 Million

Check Kilitch Drugs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kilitch Drugs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 32.6 M, Interest Expense of 72.9 M or Selling General Administrative of 25 M, as well as many indicators such as . Kilitch financial statements analysis is a perfect complement when working with Kilitch Drugs Valuation or Volatility modules.
  
This module can also supplement various Kilitch Drugs Technical models . Check out the analysis of Kilitch Drugs Correlation against competitors.

Kilitch Drugs Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.7 B2.8 B1.6 B
Slightly volatile
Short and Long Term Debt Total157.8 M284.8 M116.1 M
Slightly volatile
Other Current Liabilities14.3 M15.1 M46.4 M
Slightly volatile
Total Current Liabilities369.3 M738.5 M370 M
Slightly volatile
Total Stockholder Equity1.2 B2 B1.2 B
Slightly volatile
Property Plant And Equipment Net293 M433.1 M297.8 M
Slightly volatile
Cash228.3 M217.5 M118.5 M
Slightly volatile
Non Current Assets Total749.4 M1.1 B709.8 M
Slightly volatile
Cash And Short Term Investments474.6 M793.7 M553.9 M
Pretty Stable
Common Stock Shares Outstanding15.4 M14.3 M20.2 M
Slightly volatile
Liabilities And Stockholders Equity1.7 B2.8 B1.6 B
Slightly volatile
Inventory49.7 M83.8 M41.8 M
Slightly volatile
Other Current Assets47.5 M50 M100 M
Pretty Stable
Other Stockholder Equity917.4 M873.7 M455.6 M
Slightly volatile
Total Liabilities357.3 M579.5 M373.7 M
Slightly volatile
Total Current Assets916 M1.7 B911.5 M
Slightly volatile
Common Stock150.7 M184.9 M142 M
Slightly volatile
Accounts Payable177.6 M294.3 M170.7 M
Slightly volatile
Current Deferred Revenue59.2 M47.7 M87.5 M
Slightly volatile
Retained Earnings624.5 M968.7 M596.1 M
Slightly volatile
Short Term Investments378.1 M451 M521.8 M
Slightly volatile
Intangible Assets4.9 M5.1 M35.4 M
Very volatile
Other Liabilities584 K614.7 K2.5 M
Pretty Stable
Net Tangible Assets1.1 B1.5 B1.1 B
Pretty Stable
Other Assets0.860.980.4 M
Slightly volatile
Long Term Investments281.9 M287.7 M212.1 M
Slightly volatile
Property Plant Equipment309.3 M544.6 M276.1 M
Slightly volatile
Deferred Long Term Liabilities206.4 K154.8 K210.7 K
Slightly volatile
Short and Long Term Debt382.1 M363.9 M117.6 M
Slightly volatile
Good Will189.4 M174.4 M261.2 M
Slightly volatile
Net Invested Capital1.7 B2.4 B1.4 B
Slightly volatile
Net Working Capital499.5 M940.4 M498.9 M
Slightly volatile
Capital Surpluse306.6 M344.9 M376.1 M
Slightly volatile
Capital Stock171.5 M184.9 M157.5 M
Slightly volatile
Non Current Liabilities Other5.5 M6.2 M6.7 M
Slightly volatile
Property Plant And Equipment Gross517.6 M433.1 M587.2 M
Very volatile

Kilitch Drugs Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization32.6 M30.1 M34.8 M
Very volatile
Selling General Administrative25 M33.8 M22 M
Very volatile
Total Revenue889.7 M1.8 B742 M
Slightly volatile
Gross Profit749.2 M713.5 M332.8 M
Slightly volatile
Other Operating Expenses831.4 M1.5 B701 M
Slightly volatile
Cost Of Revenue421.4 M830.9 M412.3 M
Slightly volatile
Total Operating Expenses252.4 M474.3 M265.2 M
Slightly volatile
Selling And Marketing Expenses9 M12.8 M7.8 M
Slightly volatile
Minority Interest15.3 M11.8 M12.2 M
Slightly volatile
Interest Income4.5 M4.7 M9.5 M
Slightly volatile
Reconciled Depreciation27.4 M38.5 M24 M
Slightly volatile

Kilitch Drugs Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow239.6 M228.2 M114.3 M
Slightly volatile
Depreciation32.6 M30.1 M34.8 M
Very volatile
Capital Expenditures106 M58.1 M122.3 M
Pretty Stable
End Period Cash Flow229 M218.1 M122 M
Slightly volatile
Dividends Paid10.2 M10.8 M36.9 M
Slightly volatile
Net Borrowings21.1 M20.3 M16 M
Slightly volatile
Issuance Of Capital Stock18.2 M34.7 M47.1 M
Slightly volatile

Kilitch Fundamental Market Drivers

Cash And Short Term Investments690.2 M

About Kilitch Drugs Financial Statements

Investors use fundamental indicators, such as Kilitch Drugs' revenue or net income, to determine how well the company is positioned to perform in the future. Although Kilitch Drugs' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue47.7 M59.2 M
Total Revenue1.8 B889.7 M
Cost Of Revenue830.9 M421.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
SSentinelOne
GMGeneral Motors

Other Information on Investing in Kilitch Stock

Kilitch Drugs financial ratios help investors to determine whether Kilitch Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kilitch with respect to the benefits of owning Kilitch Drugs security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY